Medtecs International Corporation Limited (9103.TW)

TWD 5.04

(-1.95%)

Total Liabilities Summary of Medtecs International Corporation Limited

Medtecs International Corporation Limited's latest annual total liabilities in 2023 was 36.45 Million USD , up 22.62% from previous year.
Medtecs International Corporation Limited's latest quarterly total liabilities in 2024 Q2 was 36.08 Million USD , down -1.01% from previous quarter.
Medtecs International Corporation Limited reported annual total liabilities of 29.73 Million USD in 2022, up 7.47% from previous year.
Medtecs International Corporation Limited reported annual total liabilities of 27.66 Million USD in 2021, down -45.96% from previous year.
Medtecs International Corporation Limited reported quarterly total liabilities of 36.45 Million USD for 2023 Q4, up 4.86% from previous quarter.
Medtecs International Corporation Limited reported quarterly total liabilities of 36.45 Million USD for 2023 FY, up 22.62% from previous quarter.

Annual Total Liabilities Chart of Medtecs International Corporation Limited (2023 - 2009)

Historical Annual Total Liabilities of Medtecs International Corporation Limited (2023 - 2009)

Year	Total Liabilities	Total Liabilities Growth
2023	36.45 Million USD	22.62%
2022	29.73 Million USD	7.47%
2021	27.66 Million USD	-45.96%
2020	51.19 Million USD	-1.57%
2019	52.01 Million USD	4.99%
2018	49.54 Million USD	6.28%
2017	46.61 Million USD	6.48%
2016	43.77 Million USD	-10.36%
2015	48.83 Million USD	0.77%
2014	48.46 Million USD	-11.7%
2013	54.88 Million USD	-3.21%
2012	56.7 Million USD	3.37%
2011	54.85 Million USD	-8.21%
2010	59.76 Million USD	15.77%
2009	51.62 Million USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	36.08 Million USD	-1.01%
2023 Q4	36.45 Million USD	4.86%
2023 FY	36.45 Million USD	22.62%
2023 Q2	34.77 Million USD	16.94%
2022 FY	29.73 Million USD	7.47%
2022 Q4	29.73 Million USD	-39.29%
2022 Q2	48.98 Million USD	77.04%
2021 Q4	27.66 Million USD	22.49%
2021 FY	27.66 Million USD	-45.96%
2021 Q2	22.58 Million USD	-55.88%
2020 FY	51.19 Million USD	-1.57%
2020 Q4	51.19 Million USD	-22.0%
2020 Q2	65.63 Million USD	26.18%
2019 FY	52.01 Million USD	4.99%
2019 Q4	52.01 Million USD	5.88%
2019 Q2	49.12 Million USD	-0.85%
2018 Q2	50.48 Million USD	8.29%
2018 Q4	49.54 Million USD	-1.86%
2018 FY	49.54 Million USD	6.28%
2017 Q2	47.64 Million USD	8.83%
2017 Q4	46.61 Million USD	-2.16%
2017 FY	46.61 Million USD	6.48%
2016 Q4	43.77 Million USD	-9.24%
2016 FY	43.77 Million USD	-10.36%
2016 Q2	48.23 Million USD	-1.22%
2015 Q2	52.28 Million USD	7.89%
2015 FY	48.83 Million USD	0.77%
2015 Q4	48.83 Million USD	-6.6%
2014 FY	48.46 Million USD	-11.7%
2014 Q4	48.46 Million USD	-2.61%
2014 Q2	49.76 Million USD	-9.33%
2013 FY	54.88 Million USD	-3.21%
2013 Q4	54.88 Million USD	-3.06%
2013 Q2	56.61 Million USD	-0.16%
2012 FY	56.7 Million USD	3.37%
2012 Q4	56.7 Million USD	5.33%
2012 Q2	53.84 Million USD	-1.86%
2011 FY	54.85 Million USD	-8.21%
2011 Q2	61.84 Million USD	3.48%
2011 Q4	54.85 Million USD	-11.29%
2010 Q2	55.54 Million USD	7.59%
2010 FY	59.76 Million USD	15.77%
2010 Q4	59.76 Million USD	7.6%
2009 Q2	57.17 Million USD	0.0%
2009 Q4	51.62 Million USD	-9.71%
2009 FY	51.62 Million USD	0.0%

Peer Total Liabilities Comparison of Medtecs International Corporation Limited

Name	Total Liabilities	Total Liabilities Difference
Nang Kuang Pharmaceutical Co., Ltd.	1.47 Billion TWD	97.535%
Maxigen Biotech Inc.	131.88 Million TWD	72.355%
SciVision Biotech Inc.	533.66 Million TWD	93.168%
Bionime Corporation	3.3 Billion TWD	98.898%
Pegavision Corporation	3.87 Billion TWD	99.06%
Visco Vision Inc.	1.74 Billion TWD	97.907%